AFT Pharmaceuticals Limited (ASX:AFP)

Market Cap	251.92M
Revenue (ttm)	182.21M
Net Income (ttm)	10.65M
Shares Out	n/a
EPS (ttm)	0.09
PE Ratio	23.65
Forward PE	n/a
Dividend	0.01 (0.64%)
Ex-Dividend Date	Jun 19, 2024

Volume	2
Average Volume	695
Open	2.300
Previous Close	2.300
Day's Range	2.300 - 2.300
52-Week Range	2.150 - 3.160
Beta	0.35
RSI	24.26
Earnings Date	May 22, 2025

About AFT Pharmaceuticals

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, vitamins, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 110
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AFP

Financial Performance

In 2023, AFT Pharmaceuticals's revenue was 195.41 million, an increase of 24.75% compared to the previous year's 156.64 million. Earnings were 15.61 million, an increase of 46.51%.

Financial numbers in NZD